Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pekka Collin

Showing results (131-140 of 144) with videos related to

Pageof 15
Sort By:
The American Journal of Gastroenterology|April 20, 2011
Gluten-sensitive hypertransaminasemia in celiac disease: an infrequent and often subclinical findingSatu Korpimäki, Katri Kaukinen, Pekka Collin, et al.
Journal of Pediatric Gastroenterology and Nutrition|November 4, 2008
Comparison of a novel whole blood transglutaminase-based ELISA with a whole blood rapid antibody test and established conventional serological celiac disease assaysTiina Raivio, Ilma R Korponay-Szabó, Tuula Paajanen, et al.
European Journal of Gastroenterology & Hepatology|January 6, 2006
European multi-centre study on coeliac disease and non-Hodgkin lymphomaM Luisa Mearin, Carlo Catassi, Nicole Brousse, et al.
The Lancet. Gastroenterology & Hepatology|September 9, 2019
Safety and efficacy of AMG 714 in patients with type 2 refractory coeliac disease: a phase 2a, randomised, double-blind, placebo-controlled, parallel-group studyChristophe Cellier, Gerd Bouma, Tom van Gils, et al.
European Journal of Gastroenterology & Hepatology|January 14, 2005
Antiendomysial and antihuman recombinant tissue transglutaminase antibodies in the diagnosis of coeliac disease: a biopsy-proven European multicentre studyPekka Collin, Katri Kaukinen, Harald Vogelsang, et al.
European Journal of Gastroenterology & Hepatology|August 23, 2018
Vitamin D deficiency in a European inflammatory bowel disease inception cohort: an Epi-IBD studyStefania Chetcuti Zammit, Pierre Ellul, Giulia Girardin, et al.
Inflammatory Bowel Diseases|November 21, 2013
Initial disease course and treatment in an inflammatory bowel disease inception cohort in Europe: the ECCO-EpiCom cohortJohan Burisch, Natalia Pedersen, Silvja Cukovic-Cavka, et al.
The Lancet. Gastroenterology & Hepatology|February 17, 2020
Health-care costs of inflammatory bowel disease in a pan-European, community-based, inception cohort during 5 years of follow-up: a population-based studyJohan Burisch, Hillel Vardi, Doron Schwartz, et al.
Journal of Gastroenterology and Hepatology|December 19, 2018
Disease course of inflammatory bowel disease unclassified in a European population-based inception cohort: An Epi-IBD studyJohan Burisch, Stefania Chetcuti Zammit, Pierre Ellul, et al.
Gut|January 25, 2018
Natural disease course of Crohn's disease during the first 5 years after diagnosis in a European population-based inception cohort: an Epi-IBD studyJohan Burisch, Gediminas Kiudelis, Limas Kupcinskas, et al.
Pageof 15

Showing results (131-140 of 144) with videos related to

Sort By:
Pageof 15
The American Journal of Gastroenterology|April 20, 2011
Gluten-sensitive hypertransaminasemia in celiac disease: an infrequent and often subclinical findingSatu Korpimäki, Katri Kaukinen, Pekka Collin, et al.
Journal of Pediatric Gastroenterology and Nutrition|November 4, 2008
Comparison of a novel whole blood transglutaminase-based ELISA with a whole blood rapid antibody test and established conventional serological celiac disease assaysTiina Raivio, Ilma R Korponay-Szabó, Tuula Paajanen, et al.
European Journal of Gastroenterology & Hepatology|January 6, 2006
European multi-centre study on coeliac disease and non-Hodgkin lymphomaM Luisa Mearin, Carlo Catassi, Nicole Brousse, et al.
The Lancet. Gastroenterology & Hepatology|September 9, 2019
Safety and efficacy of AMG 714 in patients with type 2 refractory coeliac disease: a phase 2a, randomised, double-blind, placebo-controlled, parallel-group studyChristophe Cellier, Gerd Bouma, Tom van Gils, et al.
European Journal of Gastroenterology & Hepatology|January 14, 2005
Antiendomysial and antihuman recombinant tissue transglutaminase antibodies in the diagnosis of coeliac disease: a biopsy-proven European multicentre studyPekka Collin, Katri Kaukinen, Harald Vogelsang, et al.
European Journal of Gastroenterology & Hepatology|August 23, 2018
Vitamin D deficiency in a European inflammatory bowel disease inception cohort: an Epi-IBD studyStefania Chetcuti Zammit, Pierre Ellul, Giulia Girardin, et al.
Inflammatory Bowel Diseases|November 21, 2013
Initial disease course and treatment in an inflammatory bowel disease inception cohort in Europe: the ECCO-EpiCom cohortJohan Burisch, Natalia Pedersen, Silvja Cukovic-Cavka, et al.
The Lancet. Gastroenterology & Hepatology|February 17, 2020
Health-care costs of inflammatory bowel disease in a pan-European, community-based, inception cohort during 5 years of follow-up: a population-based studyJohan Burisch, Hillel Vardi, Doron Schwartz, et al.
Journal of Gastroenterology and Hepatology|December 19, 2018
Disease course of inflammatory bowel disease unclassified in a European population-based inception cohort: An Epi-IBD studyJohan Burisch, Stefania Chetcuti Zammit, Pierre Ellul, et al.
Gut|January 25, 2018
Natural disease course of Crohn's disease during the first 5 years after diagnosis in a European population-based inception cohort: an Epi-IBD studyJohan Burisch, Gediminas Kiudelis, Limas Kupcinskas, et al.
Pageof 15